Diabetes treatment
US6184209A · kind A · utility
7Cited by
1References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 4, 1999 |
| Grant date | Feb 6, 2001 |
| Priority date | — |
| Expiry date | Feb 4, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Diabetes Mellitus type I or II is treated by use of a peptide including an amino acid sequence comprising part of a 10 amino acid C-terminal fragment of .beta.-endorphin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.